Skip to content
10-Q

Quarterly Report

KAIROS PHARMA, LTD. KAPA

0001493152-25-023276

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 20.82M sh
Shares Diluted Q3 2025 · Sep 30, 2025 20.21M sh
Shares Diluted Q3 2025 · Sep 30, 2025 17.62M sh
Shares Diluted Q3 2025 · Sep 30, 2024 10.91M sh
Shares Diluted Q3 2025 · Sep 30, 2024 10.68M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$2.36M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$2.15M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $5.58M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.27M
Stockholders Equity Q3 2025 · Sep 30, 2025 $7.66M
Stockholders Equity Q3 2025 · Jun 30, 2025 $6M
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.78M
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.33M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$2.65M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$2.08M
Current Liabilities Q3 2025 · Sep 30, 2025 $402K
Current Liabilities Q3 2025 · Dec 31, 2024 $992K
Current Assets Q3 2025 · Sep 30, 2025 $6.66M
Current Assets Q3 2025 · Dec 31, 2024 $4.17M
Total Assets Q3 2025 · Sep 30, 2025 $8.07M
Total Assets Q3 2025 · Dec 31, 2024 $5.77M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.07
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.23
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.15
Eps Basic Q3 2025 · Sep 30, 2025 −$0.07
Eps Basic Q3 2025 · Sep 30, 2025 −$0.23
Eps Basic Q3 2025 · Sep 30, 2024 −$0.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.15
Sga Expense Q3 2025 · Sep 30, 2025 $827K
Sga Expense Q3 2025 · Sep 30, 2025 $2.56M
Sga Expense Q3 2025 · Sep 30, 2024 $369K
Sga Expense Q3 2025 · Sep 30, 2024 $655K
Rd Expense Q3 2025 · Sep 30, 2025 $608K
Rd Expense Q3 2025 · Sep 30, 2025 $1.6M
Rd Expense Q3 2025 · Sep 30, 2024 $14K
Rd Expense Q3 2025 · Sep 30, 2024 $242K
Net Income Q3 2025 · Sep 30, 2025 −$1.4M
Net Income Q3 2025 · Sep 30, 2025 −$4.08M
Net Income Q3 2025 · Sep 30, 2024 −$1.05M
Net Income Q3 2025 · Sep 30, 2024 −$1.62M
Operating Income Q3 2025 · Sep 30, 2025 −$1.44M
Operating Income Q3 2025 · Sep 30, 2025 −$4.16M
Operating Income Q3 2025 · Sep 30, 2024 −$383K
Operating Income Q3 2025 · Sep 30, 2024 −$897K